Qing Zhao, MD, PhD

Publications

• Published 9/26/2025

  Lu Z, Zhou Y, Fan W, Choksi S, Sultan L, Katz MH, Wang DS, Zhao Q, Yang S. Biphasic (squamoid) papillary renal cell carcinoma: a distinct molecular and morphologic subtype within the PRCC spectrum. Virchows Arch. 2025 Sep 26. PMID: 41006900.

  Read at: PubMed

• Published 8/23/2025

  Lu Z, Zhao Q, Xu H, Katz MH, Wang DS, Andry CD, Yang S. Molecular and Clinicopathological Profiling of Clear Cell Renal Cell Carcinoma with Rhabdoid Features: An Integrative Pathway-Based Stratification Approach. Cancers (Basel). 2025 Aug 23; 17(17). PMID: 40940841.

  Read at: PubMed

• Published 9/22/2024

  Xu EJK, Smith BE, Conce Alberto WD, Walsh MJ, Lim B, Hoffman MT, Qiang L, Dong J, Garmilla A, Zhao QH, Perez CR, Gaglione SA, Dobson CS, Dougan M, Dougan SK, Birnbaum ME. Peptide-MHC-targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells. bioRxiv. 2024 Sep 22. PMID: 39345591.

  Read at: PubMed

• Published 3/20/2024

  Shaikh SD, Jacoba I, Sun N, Chung E, Kim HT, Zhao Q, Weber HC. A Clinicopathological Appraisal of Duodenal Neuroendocrine Tumors at a Racially Diverse Safety Net Hospital. Am J Gastroenterol. 2024 Mar 20. PMID: 38345246.

  Read at: PubMed

• Published 11/13/2023

  Ma L, Sullivan TB, Rieger-Christ KM, Yambayev I, Zhao Q, Higgins SE, Yilmaz OH, Sultan L, Servais EL, Suzuki K, Burks EJ. Vascular invasion predicts the subgroup of lung adenocarcinomas =2.0 cm at risk of poor outcome treated by wedge resection compared to lobectomy. JTCVS Open. 2023 Dec; 16:938-947. PMID: 38204657.

  Read at: PubMed

View All 46 Publications:   View Full Profile in BUMC